
Dr. Katja Sänger tests the NeuMoDx 288 Molecular System in one of the largest medical labs in Eastern Germany. Since the interview (February 2020), Dr. Sanger’s lab - like all diagnostic labs worldwide - has experienced an unprecedented surge in testing due to the COVID-19 pandemic, running more than 1000 SARS-CoV-2 samples each day in addition to their usual workload. This increased workload is expected to continue as countries encounter new waves of the pandemic and approach the winter season.
So far, the NeuMoDx test series has been consistently convincing.
Dr. Katja Sänger, Head of Molecular Pathogen Diagnostics Lab, MVZ Labor Dr. Reising-Ackermann & Kollegen, Leipzig
For our molecular biological pathogen diagnostics, we use systems from only two suppliers – those which, in our experience, are reliable, easy to operate, and low maintenance. QIAGEN’s is one of them.
Dr. Katja Sänger, Head of Molecular Pathogen Diagnostics Lab, MVZ Labor Dr. Reising-Ackermann & Kollegen, Leipzig
In need of accurate and timely clinical laboratory results?
NeuMoDx Molecular Systems provide the industry’s first true continuous random-access solution.